Cargando…
A Modified R-Type Bacteriocin Specifically Targeting Clostridium difficile Prevents Colonization of Mice without Affecting Gut Microbiota Diversity
Clostridium difficile is a leading cause of nosocomial infections worldwide and has become an urgent public health threat requiring immediate attention. Epidemic lineages of the BI/NAP1/027 strain type have emerged and spread through health care systems across the globe over the past decade. Limitin...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society of Microbiology
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4453579/ https://www.ncbi.nlm.nih.gov/pubmed/25805733 http://dx.doi.org/10.1128/mBio.02368-14 |
_version_ | 1782374477517029376 |
---|---|
author | Gebhart, Dana Lok, Stephen Clare, Simon Tomas, Myreen Stares, Mark Scholl, Dean Donskey, Curtis J. Lawley, Trevor D. Govoni, Gregory R. |
author_facet | Gebhart, Dana Lok, Stephen Clare, Simon Tomas, Myreen Stares, Mark Scholl, Dean Donskey, Curtis J. Lawley, Trevor D. Govoni, Gregory R. |
author_sort | Gebhart, Dana |
collection | PubMed |
description | Clostridium difficile is a leading cause of nosocomial infections worldwide and has become an urgent public health threat requiring immediate attention. Epidemic lineages of the BI/NAP1/027 strain type have emerged and spread through health care systems across the globe over the past decade. Limiting person-to-person transmission and eradicating C. difficile, especially the BI/NAP1/027 strain type, from health care facilities are difficult due to the abundant shedding of spores that are impervious to most interventions. Effective prophylaxis for C. difficile infection (CDI) is lacking. We have genetically modified a contractile R-type bacteriocin (“diffocin”) from C. difficile strain CD4 to kill BI/NAP1/027-type strains for this purpose. The natural receptor binding protein (RBP) responsible for diffocin targeting was replaced with a newly discovered RBP identified within a prophage of a BI/NAP1/027-type target strain by genome mining. The resulting modified diffocins (a.k.a. Avidocin-CDs), Av-CD291.1 and Av-CD291.2, were stable and killed all 16 tested BI/NAP1/027-type strains. Av-CD291.2 administered in drinking water survived passage through the mouse gastrointestinal (GI) tract, did not detectably alter the mouse gut microbiota or disrupt natural colonization resistance to C. difficile or the vancomycin-resistant Enterococcus faecium (VREF), and prevented antibiotic-induced colonization of mice inoculated with BI/NAP1/027-type spores. Given the high incidence and virulence of the pathogen, preventing colonization by BI/NAP1/027-type strains and limiting their transmission could significantly reduce the occurrence of the most severe CDIs. This modified diffocin represents a prototype of an Avidocin-CD platform capable of producing targetable, precision anti-C. difficile agents that can prevent and potentially treat CDIs without disrupting protective indigenous microbiota. |
format | Online Article Text |
id | pubmed-4453579 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2015 |
publisher | American Society of Microbiology |
record_format | MEDLINE/PubMed |
spelling | pubmed-44535792015-06-03 A Modified R-Type Bacteriocin Specifically Targeting Clostridium difficile Prevents Colonization of Mice without Affecting Gut Microbiota Diversity Gebhart, Dana Lok, Stephen Clare, Simon Tomas, Myreen Stares, Mark Scholl, Dean Donskey, Curtis J. Lawley, Trevor D. Govoni, Gregory R. mBio Research Article Clostridium difficile is a leading cause of nosocomial infections worldwide and has become an urgent public health threat requiring immediate attention. Epidemic lineages of the BI/NAP1/027 strain type have emerged and spread through health care systems across the globe over the past decade. Limiting person-to-person transmission and eradicating C. difficile, especially the BI/NAP1/027 strain type, from health care facilities are difficult due to the abundant shedding of spores that are impervious to most interventions. Effective prophylaxis for C. difficile infection (CDI) is lacking. We have genetically modified a contractile R-type bacteriocin (“diffocin”) from C. difficile strain CD4 to kill BI/NAP1/027-type strains for this purpose. The natural receptor binding protein (RBP) responsible for diffocin targeting was replaced with a newly discovered RBP identified within a prophage of a BI/NAP1/027-type target strain by genome mining. The resulting modified diffocins (a.k.a. Avidocin-CDs), Av-CD291.1 and Av-CD291.2, were stable and killed all 16 tested BI/NAP1/027-type strains. Av-CD291.2 administered in drinking water survived passage through the mouse gastrointestinal (GI) tract, did not detectably alter the mouse gut microbiota or disrupt natural colonization resistance to C. difficile or the vancomycin-resistant Enterococcus faecium (VREF), and prevented antibiotic-induced colonization of mice inoculated with BI/NAP1/027-type spores. Given the high incidence and virulence of the pathogen, preventing colonization by BI/NAP1/027-type strains and limiting their transmission could significantly reduce the occurrence of the most severe CDIs. This modified diffocin represents a prototype of an Avidocin-CD platform capable of producing targetable, precision anti-C. difficile agents that can prevent and potentially treat CDIs without disrupting protective indigenous microbiota. American Society of Microbiology 2015-03-24 /pmc/articles/PMC4453579/ /pubmed/25805733 http://dx.doi.org/10.1128/mBio.02368-14 Text en Copyright © 2015 Gebhart et al. http://creativecommons.org/licenses/by/3.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution 3.0 Unported license (http://creativecommons.org/licenses/by/3.0/) . |
spellingShingle | Research Article Gebhart, Dana Lok, Stephen Clare, Simon Tomas, Myreen Stares, Mark Scholl, Dean Donskey, Curtis J. Lawley, Trevor D. Govoni, Gregory R. A Modified R-Type Bacteriocin Specifically Targeting Clostridium difficile Prevents Colonization of Mice without Affecting Gut Microbiota Diversity |
title | A Modified R-Type Bacteriocin Specifically Targeting Clostridium difficile Prevents Colonization of Mice without Affecting Gut Microbiota Diversity |
title_full | A Modified R-Type Bacteriocin Specifically Targeting Clostridium difficile Prevents Colonization of Mice without Affecting Gut Microbiota Diversity |
title_fullStr | A Modified R-Type Bacteriocin Specifically Targeting Clostridium difficile Prevents Colonization of Mice without Affecting Gut Microbiota Diversity |
title_full_unstemmed | A Modified R-Type Bacteriocin Specifically Targeting Clostridium difficile Prevents Colonization of Mice without Affecting Gut Microbiota Diversity |
title_short | A Modified R-Type Bacteriocin Specifically Targeting Clostridium difficile Prevents Colonization of Mice without Affecting Gut Microbiota Diversity |
title_sort | modified r-type bacteriocin specifically targeting clostridium difficile prevents colonization of mice without affecting gut microbiota diversity |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4453579/ https://www.ncbi.nlm.nih.gov/pubmed/25805733 http://dx.doi.org/10.1128/mBio.02368-14 |
work_keys_str_mv | AT gebhartdana amodifiedrtypebacteriocinspecificallytargetingclostridiumdifficilepreventscolonizationofmicewithoutaffectinggutmicrobiotadiversity AT lokstephen amodifiedrtypebacteriocinspecificallytargetingclostridiumdifficilepreventscolonizationofmicewithoutaffectinggutmicrobiotadiversity AT claresimon amodifiedrtypebacteriocinspecificallytargetingclostridiumdifficilepreventscolonizationofmicewithoutaffectinggutmicrobiotadiversity AT tomasmyreen amodifiedrtypebacteriocinspecificallytargetingclostridiumdifficilepreventscolonizationofmicewithoutaffectinggutmicrobiotadiversity AT staresmark amodifiedrtypebacteriocinspecificallytargetingclostridiumdifficilepreventscolonizationofmicewithoutaffectinggutmicrobiotadiversity AT scholldean amodifiedrtypebacteriocinspecificallytargetingclostridiumdifficilepreventscolonizationofmicewithoutaffectinggutmicrobiotadiversity AT donskeycurtisj amodifiedrtypebacteriocinspecificallytargetingclostridiumdifficilepreventscolonizationofmicewithoutaffectinggutmicrobiotadiversity AT lawleytrevord amodifiedrtypebacteriocinspecificallytargetingclostridiumdifficilepreventscolonizationofmicewithoutaffectinggutmicrobiotadiversity AT govonigregoryr amodifiedrtypebacteriocinspecificallytargetingclostridiumdifficilepreventscolonizationofmicewithoutaffectinggutmicrobiotadiversity AT gebhartdana modifiedrtypebacteriocinspecificallytargetingclostridiumdifficilepreventscolonizationofmicewithoutaffectinggutmicrobiotadiversity AT lokstephen modifiedrtypebacteriocinspecificallytargetingclostridiumdifficilepreventscolonizationofmicewithoutaffectinggutmicrobiotadiversity AT claresimon modifiedrtypebacteriocinspecificallytargetingclostridiumdifficilepreventscolonizationofmicewithoutaffectinggutmicrobiotadiversity AT tomasmyreen modifiedrtypebacteriocinspecificallytargetingclostridiumdifficilepreventscolonizationofmicewithoutaffectinggutmicrobiotadiversity AT staresmark modifiedrtypebacteriocinspecificallytargetingclostridiumdifficilepreventscolonizationofmicewithoutaffectinggutmicrobiotadiversity AT scholldean modifiedrtypebacteriocinspecificallytargetingclostridiumdifficilepreventscolonizationofmicewithoutaffectinggutmicrobiotadiversity AT donskeycurtisj modifiedrtypebacteriocinspecificallytargetingclostridiumdifficilepreventscolonizationofmicewithoutaffectinggutmicrobiotadiversity AT lawleytrevord modifiedrtypebacteriocinspecificallytargetingclostridiumdifficilepreventscolonizationofmicewithoutaffectinggutmicrobiotadiversity AT govonigregoryr modifiedrtypebacteriocinspecificallytargetingclostridiumdifficilepreventscolonizationofmicewithoutaffectinggutmicrobiotadiversity |